Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 23Neoplasms 12Lymphoma 4Unspecified Adult Solid Tumor, Protocol Specific 3Solid Tumors 2Recurrence 2Neuroblastoma 2Neoplasm Metastasis 2Lymphoma, Non-Hodgkin 2Glioma 2Glioblastoma 2Brain Neoplasms 2Thromboembolism 1Ovarian Neoplasms 1Oligodendroglioma 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Hematologic Neoplasms 1Hematologic Diseases 1Granulosa Cell Tumor 1Genetic Diseases, Inborn 1Castration-resistant Prostate Cancer 1Carcinoma 1Breast Neoplasms 1Astrocytoma 1Advanced Cancer 1

Interventions

temsirolimus 2Sirolimus 2Gemcitabine 2AZD 6244 2ARQ 197 2veliparib 1sargramostim 1pegfilgrastim 1ixabepilone 1cixutumumab 1belinostat 1Vorinostat 1Topotecan 1Tolbutamide 1Taxes 1Sunitinib 1Rifampin 1Paclitaxel 1Omeprazole 1Midazolam 1Ketoconazole 1Isotretinoin 1Irinotecan 1Introns 1Interferon alpha-2 1Hydroxychloroquine 1Erlotinib Hydrochloride 1Epothilones 1Dextromethorphan 1Colony-Stimulating Factors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Adult Solid Neoplasm × Ketoconazole × Clear all
NCT01218620 2014-12-23

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
17 enrolled

Adult Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡